Back to Search Start Over

Six-year duration of adjuvant imatinib in high-risk GIST: more to come.

Authors :
Blay JY
Schiffler C
Chabaud S
Perolc D
Le Cesne A
Source :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Mar; Vol. 36 (3), pp. 346-347. Date of Electronic Publication: 2024 Dec 02.
Publication Year :
2025

Details

Language :
English
ISSN :
1569-8041
Volume :
36
Issue :
3
Database :
MEDLINE
Journal :
Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :
Editorial & Opinion
Accession number :
39631623
Full Text :
https://doi.org/10.1016/j.annonc.2024.11.013